Search results for "EU ORPHAN DRUG|Withdrawn|Treatment of amyotrophic lateral sclerosis" in comments (approximate match)
Showing 1 - 2 of 2 results
Class (Stereo):
CHEMICAL (ABSOLUTE)
Conditions:
PYM50018 (also known as Myogane or SARSAGENIN) has demonstrated neuroprotective effects in several preclinical models. It was observed that PYM50018 protects against neuronal damage, increases neurite outgrowth, reverses oxidative damage and reversed...
Class (Stereo):
CHEMICAL (ACHIRAL)
Xaliproden is an orally active 5HT1-A receptor antagonist that was being developed by Sanofi. It has been evaluated for the treatment of Alzheimer's disease and amyotrophic lateral sclerosis (ALS), and protection against peripheral neurotoxicity asso...